Mutations in GCK May Lead to MODY2 by Reducing Glycogen Synthesis

Area of Science:

• Genetics
• Endocrinology
• Molecular Biology

Background:

• Maturity-onset diabetes of the young type-2 (MODY2), also known as GCK-MODY, results from glucokinase (GCK) gene mutations.
• MODY2 typically presents with mild, stable hyperglycemia from birth and rarely leads to diabetes complications, with dietary management preferred over insulin.

Purpose of the Study:

• To identify novel mutations in the GCK gene associated with MODY2.
• To investigate the functional impact of identified GCK mutations on glucose metabolism and glycogen synthesis.

Main Methods:

• Genetic sequencing to identify mutations in the GCK gene.
• Bioinformatic analysis to assess mutation conservation and pathogenicity.
• Functional studies to evaluate the effect of mutations on insulin secretion and glycogen synthesis.

Main Results:

• Six GCK gene mutations were identified, including four novel and two previously reported mutations, all located in highly conserved regions.
• Missense mutations were strongly predicted as pathogenic by online programs.
• Functional studies revealed that GCK mutations do not affect insulin secretion but significantly decrease glycogen synthesis, leading to hyperglycemia.

Conclusions:

• GCK gene mutations impair glycogen synthesis, causing hyperglycemia in MODY2.
• This study provides novel insights and methodologies for identifying pathogenic GCK mutations, advancing the understanding and diagnosis of MODY2.